{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:36:10Z","timestamp":1761510970742},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T00:00:00Z","timestamp":1355788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/sc.2012.164","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T10:21:30Z","timestamp":1355826090000},"page":"306-309","source":"Crossref","is-referenced-by-count":24,"title":["Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion"],"prefix":"10.1038","volume":"51","author":[{"given":"J","family":"Krebs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Pannek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"BFsc2012164_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0022-5347(17)37254-3","volume":"147","author":"RG Gerridzen","year":"1992","unstructured":"Gerridzen RG, Thijssen AM, Dehoux E . Risk factors for upper tract deterioration in chronic spinal cord injury patients. J Urol 1992; 147: 416\u2013418.","journal-title":"J Urol"},{"key":"BFsc2012164_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0022-5347(17)58506-7","volume":"117","author":"RH Hackler","year":"1977","unstructured":"Hackler RH . A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol 1977; 117: 486\u2013488.","journal-title":"J Urol"},{"key":"BFsc2012164_CR3","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1097\/00007632-200112151-00022","volume":"26","author":"AS Burns","year":"2001","unstructured":"Burns AS, Rivas DA, Ditunno JF . The management of neurogenic bladder and sexual dysfunction after spinal cord injury. Spine 2001; 26: S129\u2013S136.","journal-title":"Spine"},{"key":"BFsc2012164_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2009.04.028","volume":"56","author":"M Stohrer","year":"2009","unstructured":"Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 2009; 56: 81\u201388.","journal-title":"Eur Urol"},{"key":"BFsc2012164_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.sc.3100638","volume":"36","author":"HL Frankel","year":"1998","unstructured":"Frankel HL, Coll JR, Charlifue SW, Whiteneck GG, Gardner BP, Jamous MA et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord 1998; 36: 266\u2013274.","journal-title":"Spinal Cord"},{"key":"BFsc2012164_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sc.2011.110","volume":"50","author":"G del Popolo","year":"2012","unstructured":"del Popolo G, Mencarini M, Nelli F, Lazzeri M . Controversy over the pharmacological treatments of storage symptoms in spinal cord injury patients: a literature overview. Spinal Cord 2012; 50: 8\u201313.","journal-title":"Spinal Cord"},{"key":"BFsc2012164_CR7","doi-asserted-by":"publisher","first-page":"e16718","DOI":"10.1371\/journal.pone.0016718","volume":"6","author":"TM Kessler","year":"2011","unstructured":"Kessler TM, Bachmann LM, Minder C, L\u00f6hrer D, Umbehr M, Sch\u00fcnemann HJ et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One 2011; 6: e16718.","journal-title":"PLoS One"},{"key":"BFsc2012164_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1464-410X.2009.09036.x","volume":"105","author":"JS Benner","year":"2010","unstructured":"Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M et al. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int 2010; 105: 1276\u20131282.","journal-title":"BJU Int"},{"key":"BFsc2012164_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1248\/bpb.30.54","volume":"30","author":"A Ohtake","year":"2007","unstructured":"Ohtake A, Saitoh C, Yuyama H, Ukai M, Okutsu H, Noguchi Y et al. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Biol Pharm Bull 2007; 30: 54\u201358.","journal-title":"Biol Pharm Bull"},{"key":"BFsc2012164_CR10","first-page":"CD005429","volume":"1","author":"P Madhuvrata","year":"2012","unstructured":"Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ . Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 2012; 1: CD005429.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFsc2012164_CR11","doi-asserted-by":"publisher","first-page":"834753","DOI":"10.1155\/2011\/834753","volume":"2011","author":"F van Rey","year":"2011","unstructured":"van Rey F, Heesakkers J . Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study. Adv Urol 2011; 2011: 834753.","journal-title":"Adv Urol"},{"key":"BFsc2012164_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U","volume":"18","author":"M Stohrer","year":"1999","unstructured":"Stohrer M, Goepel M, Kondo A, Kramer G, Madersbacher H, Millard R et al. The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 1999; 18: 139\u2013158.","journal-title":"Neurourol Urodyn"},{"key":"BFsc2012164_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/nau.10066","volume":"21","author":"W Schafer","year":"2002","unstructured":"Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002; 21: 261\u2013274.","journal-title":"Neurourol Urodyn"},{"key":"BFsc2012164_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1442-2042.2010.02602.x","volume":"17","author":"Y Tanaka","year":"2010","unstructured":"Tanaka Y, Masumori N, Tsukamoto T . Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder. Int J Urol 2010; 17: 796\u2013800.","journal-title":"Int J Urol"},{"key":"BFsc2012164_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61: 37\u201349.","journal-title":"Urology"},{"key":"BFsc2012164_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11255-011-0059-y","volume":"44","author":"L Lowenstein","year":"2012","unstructured":"Lowenstein L, Kenton K, Mueller ER, Brubaker L, Sabo E, Durazo-Arivzu RA et al. Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome. Int Urol Nephrol 2012; 44: 425\u2013429.","journal-title":"Int Urol Nephrol"},{"key":"BFsc2012164_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/j.1447-0756.2010.01493.x","volume":"37","author":"SM Hsiao","year":"2011","unstructured":"Hsiao SM, Chang TC, Wu WY, Chen CH, Yu HJ, Lin HH . Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome. J Obstet Gynaecol Res 2011; 37: 1084\u20131091.","journal-title":"J Obstet Gynaecol Res"},{"key":"BFsc2012164_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/nau.20319","volume":"26","author":"M Nosseir","year":"2007","unstructured":"Nosseir M, Hinkel A, Pannek J . Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007; 26: 228\u2013233.","journal-title":"Neurourol Urodyn"},{"key":"BFsc2012164_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.eururo.2005.05.015","volume":"48","author":"CR Chapple","year":"2005","unstructured":"Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T et al. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005; 48: 464\u2013470.","journal-title":"Eur Urol"},{"key":"BFsc2012164_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/j.1742-1241.2008.01898.x","volume":"62","author":"MS Choo","year":"2008","unstructured":"Choo MS, Lee JZ, Lee JB, Kim YH, Jung HC, Lee KS et al. Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study. Int J Clin Pract 2008; 62: 1675\u20131683.","journal-title":"Int J Clin Pract"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sc2012164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc2012164","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc2012164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:22:55Z","timestamp":1684621375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sc2012164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFsc2012164"],"URL":"https:\/\/doi.org\/10.1038\/sc.2012.164","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,18]]}}}